Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Guzzo

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
American Journal of Cancer Research|April 14, 2025
The impact of telemedicine on racial and ethnic disparities in oncologic care during the COVID-19 pandemicBrian D Cortese, Khalid Y Alkhatib, I Mitchell Harmatz, et al.
Urologic Oncology|August 23, 2011
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillanceThomas J Guzzo, Matthew J Resnick, Daniel J Canter, et al.
Urologic Oncology|June 30, 2021
Outcomes of mohs microgrpahic resection for cutaneous malignancy involving the scrotumDaniel Roberson, Raju Chelluri, Alexander J Skokan, et al.
Prostate Cancer and Prostatic Diseases|October 11, 2023
Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 menMatthew Epstein, Kaynaat Syed, John Danella, et al.
Cancer|January 7, 2014
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710John P Christodouleas, Brian C Baumann, Jiwei He, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2012
Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapyBrian C Baumann, Thomas J Guzzo, Jiwei He, et al.
The Journal of Urology|February 6, 2019
Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURCMahesh Botejue, Daniel Abbott, John Danella, et al.
Urology|July 26, 2020
Stakeholder Perspective on Opioid Stewardship After Prostatectomy: Evaluating Barriers and Facilitators From the Pennsylvania Urology Regional CollaborativeDaniel J Lee, Ruchika Talwar, James Ding, et al.
International Urology and Nephrology|June 26, 2024
Oncologic control and predictors of urologic reconstruction after Mohs micrographic surgery for low-risk penile malignancyBrian D Cortese, Raju Chelluri, Alexander J Skokan, et al.
The Journal of Urology|April 22, 2025
Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative StudyKhalid Y Alkhatib, Joseph G Cheaib, Maximilian Pallauf, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
American Journal of Cancer Research|April 14, 2025
The impact of telemedicine on racial and ethnic disparities in oncologic care during the COVID-19 pandemicBrian D Cortese, Khalid Y Alkhatib, I Mitchell Harmatz, et al.
Urologic Oncology|August 23, 2011
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillanceThomas J Guzzo, Matthew J Resnick, Daniel J Canter, et al.
Urologic Oncology|June 30, 2021
Outcomes of mohs microgrpahic resection for cutaneous malignancy involving the scrotumDaniel Roberson, Raju Chelluri, Alexander J Skokan, et al.
Prostate Cancer and Prostatic Diseases|October 11, 2023
Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 menMatthew Epstein, Kaynaat Syed, John Danella, et al.
Cancer|January 7, 2014
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710John P Christodouleas, Brian C Baumann, Jiwei He, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2012
Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapyBrian C Baumann, Thomas J Guzzo, Jiwei He, et al.
The Journal of Urology|February 6, 2019
Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURCMahesh Botejue, Daniel Abbott, John Danella, et al.
Urology|July 26, 2020
Stakeholder Perspective on Opioid Stewardship After Prostatectomy: Evaluating Barriers and Facilitators From the Pennsylvania Urology Regional CollaborativeDaniel J Lee, Ruchika Talwar, James Ding, et al.
International Urology and Nephrology|June 26, 2024
Oncologic control and predictors of urologic reconstruction after Mohs micrographic surgery for low-risk penile malignancyBrian D Cortese, Raju Chelluri, Alexander J Skokan, et al.
The Journal of Urology|April 22, 2025
Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative StudyKhalid Y Alkhatib, Joseph G Cheaib, Maximilian Pallauf, et al.
Pageof 18